These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17933704)

  • 1. Impact of low prostate specific antigen on prostate cancer--a rare case report.
    Schneider HB
    Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate cancer in a relatively young adult: a case report].
    Suzuki T; Togo Y; Yasuda K; Yamamoto H; Kokura K
    Hinyokika Kiyo; 2008 Feb; 54(2):139-42. PubMed ID: 18323175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endometrioid adenocarcinoma of the prostate: a case report].
    Tsutahara K; Fukuhara S; Mori N; Hara T; Yamaguchi S; Adachi S; Fujisue K
    Hinyokika Kiyo; 2004 Sep; 50(9):649-52. PubMed ID: 15518134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Walz J; Haese A; Scattoni V; Steuber T; Chun FK; Briganti A; Montorsi F; Graefen M; Huland H; Karakiewicz PI
    Cancer; 2008 Nov; 113(10):2695-703. PubMed ID: 18853417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive probability of serum prostate-specific antigen for prostate cancer: an approach using Bayes rule.
    Vollmer RT
    Am J Clin Pathol; 2006 Mar; 125(3):336-42. PubMed ID: 16613336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH; Roobol MJ
    Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic meningeal carcinomatosis with low serum level of prostate-specific antigen.
    Honda M; Miyagawa I
    Urology; 2005 Dec; 66(6):1320. PubMed ID: 16360475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extremely high PSA (250ng/ml) in a patient with localised prostatic carcinoma.
    Colgan G; O'Brien MF; Ahmad I; Thornhill JA
    Ir Med J; 2005 Jan; 98(1):29. PubMed ID: 15782735
    [No Abstract]   [Full Text] [Related]  

  • 12. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.
    Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR
    Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Kim et al.: detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/ml (Urology 2010;76:919-922).
    Shenoy SP; Marla PK; Adappa KK
    Urology; 2011 Apr; 77(4):1013-4; author reply 1014. PubMed ID: 21477737
    [No Abstract]   [Full Text] [Related]  

  • 14. Is routine digital rectal examination required for the followup of prostate cancer?
    Warren KS; McFarlane JP
    J Urol; 2007 Jul; 178(1):115-9. PubMed ID: 17499293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of pathological PSA values by the general practitioner--observation or intervention?].
    Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V
    Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patients less than 50 years: is there a need to lower the PSA cutoff point?
    Hekal IA
    Prostate Cancer Prostatic Dis; 2009; 12(2):148-51. PubMed ID: 18825164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
    Canby-Hagino E; Hernandez J; Brand TC; Troyer DA; Higgins B; Ankerst DP; Thompson IM; Leach RJ; Parekh DJ
    Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of prostate cancer detected by digital rectal examination only.
    Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ
    Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK; Chung MK; Ryu SB; Lee KH;
    Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
    Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.